- Trials with a EudraCT protocol (53)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
53 result(s) found for: Transthoracic Echocardiography.
Displaying page 1 of 3.
EudraCT Number: 2008-002332-15 | Sponsor Protocol Number: D1840M00006 | Start Date*: 2008-09-15 |
Sponsor Name:AstraZeneca AB | ||
Full Title: A randomised, double-blind, placebo-controlled study to evaluate the transthoracic Doppler echocardiography method as a non-invasive method for coronary function measurements; ability to detect sho... | ||
Medical condition: In this study the IMP, rosuvastatin, is used as a tool compound for creating favourable lipid-altering, anti-inflammatory or other pleiotropic effects which are believed to change coronary flow res... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: SE (Completed) | ||
Trial results: View results |
EudraCT Number: 2006-000357-22 | Sponsor Protocol Number: SonoV/BRA/013 | Start Date*: Information not available in EudraCT | |||||||||||
Sponsor Name:Bracco Imaging Deutschland GmbH | |||||||||||||
Full Title: ASSESSMENT OF GLOBAL AND REGIONAL LEFT VENTRICULAR FUNCTION AT REST AND DURING DOBUTAMINE STRESS WITH SONOVUE®-ENHANCED REALTIME 3D-ECHOCARDIOGRAPHY | |||||||||||||
Medical condition: Echocardiography | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Prematurely Ended) BE (Completed) FR (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2015-005615-32 | Sponsor Protocol Number: SPIHF-203 | Start Date*: 2016-05-18 |
Sponsor Name:Stealth BioTherapeutics Inc. | ||
Full Title: A Phase 2 Randomized, Double-Blinded, Placebo-Controlled Study to Evaluate the Effects of 4 Weeks Treatment with Subcutaneous Elamipretide on Left Ventricular Function in Subjects with Stable Heart... | ||
Medical condition: Heart failure with preserved ejection fraction (HFpEF) | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: DE (Completed) | ||
Trial results: View results |
EudraCT Number: 2022-000513-14 | Sponsor Protocol Number: NBK154/2/2021 | Start Date*: 2023-03-08 |
Sponsor Name:Medical University of Gdańsk | ||
Full Title: Evaluation of the Efficacy of Valsartan in Slowing Down Aortic Root Dilatation in Children and Young Adults with Marfan-type Heritable Thoracic Aortic Diseases – Valsar-TAD, a randomised, double-b... | ||
Medical condition: Marfan Syndrome Diseases related to Marfan syndrome (rare diseases with aneurysms of the thoracic aorta and dissection of the aorta), among others: Loeys-Dietz syndrome, Vascular type of Ehlers-Da... | ||
Disease: | ||
Population Age: Children, Adolescents, Under 18, Adults | Gender: Male, Female | |
Trial protocol: PL (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2017-000240-17 | Sponsor Protocol Number: ESTIMATE | Start Date*: 2017-05-02 | |||||||||||
Sponsor Name:Bispebjerg University Hospital | |||||||||||||
Full Title: Effect of SGLT2 inhibition on coronary microvascular function in type 2 diabetes | |||||||||||||
Medical condition: Coronary microvascular function in patients with type 2 diabetes | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2014-003338-15 | Sponsor Protocol Number: RBHP2014ELJEZI | Start Date*: 2014-12-01 | |||||||||||
Sponsor Name:CHU de Clermont-Ferrand | |||||||||||||
Full Title: Role of Nitric Oxide (NO) in pre-oxygenation before anesthetic induction in patients with Pulmonary Hypertension (PH) in cardiac surgery. Feasibility study. | |||||||||||||
Medical condition: - Cardiac surgery open heart - Pulmonary Hypertension with PAPs> 40 mmHg secondary to left heart disease or COPD (class 2 or 3), diagnosed by preoperative right heart catheterization or transthora... | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2006-000460-90 | Sponsor Protocol Number: AGO/2006/002 | Start Date*: 2006-03-09 |
Sponsor Name:University Hospital Ghent | ||
Full Title: Echocardiographic study of the haemodynamic effects of remifentanil with and without glycopyrrolate in healthy children | ||
Medical condition: ASA I and II children | ||
Disease: | ||
Population Age: Children, Under 18 | Gender: Male, Female | |
Trial protocol: BE (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2019-002571-33 | Sponsor Protocol Number: 49RC19_0106 | Start Date*: 2019-08-28 |
Sponsor Name:CHU Angers | ||
Full Title: Transcutaneous measurement of oxygen during transient hyperoxia | ||
Medical condition: Any patient with a cardiac output measurement | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: FR (Completed) | ||
Trial results: View results |
EudraCT Number: 2013-004776-35 | Sponsor Protocol Number: 260576 | Start Date*: 2014-04-17 | |||||||||||||||||||||
Sponsor Name:Radboud University Medical Centre Nijmegen | |||||||||||||||||||||||
Full Title: Cross-sectional study of 24-hour ambulatory blood pressure measurements and left ventricular mass using echocardiograms in late adolescents and adults with ADHD (ADDUCE protocol WP8 (cardiovascular)) | |||||||||||||||||||||||
Medical condition: Cardiovascular functioning in Attention deficit hyperactivity disorder following 3 years of treatment with methylphenidate | |||||||||||||||||||||||
|
|||||||||||||||||||||||
Population Age: Adolescents, Under 18, Adults | Gender: Male, Female | ||||||||||||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) | |||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2020-001617-21 | Sponsor Protocol Number: 72864 | Start Date*: 2020-08-27 |
Sponsor Name:Aarhus University Hospital | ||
Full Title: The Effect of Trimetazidine on Mitochondrial Function, Myocardial Performance, and Invasive Hemodynamics in Patients Diagnosed with Wild-Type Transthyretin Cardiac Amyloidosis. | ||
Medical condition: Wild-Type Transthyretin Cardiac Amyloidosis | ||
Disease: | ||
Population Age: Elderly | Gender: Male, Female | |
Trial protocol: DK (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2018-002701-59 | Sponsor Protocol Number: IIBSP-CAR-2018-71 | Start Date*: 2019-04-12 |
Sponsor Name:Institut de Recerca Hospital de la Santa Creu i Sant Pau | ||
Full Title: Randomized, open and multi-center clinical trial to compare the efficacy and safety of Buckberg vs Del Nido cardioplegia in isolated aortic valve replacement | ||
Medical condition: Myocardial protection | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: ES (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2018-004063-31 | Sponsor Protocol Number: FIM-PRELEVD-2018-01 | Start Date*: 2019-04-26 |
Sponsor Name:Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud (FIMABIS) | ||
Full Title: Mechanisms of cardio and nephroprotection in patients who are going on cardiac surgery with right ventricular dysfunction, with preoperative treatment of levosimendan compared with placebo. (PREL... | ||
Medical condition: Perioperative right ventricle dysfunction | ||
Disease: | ||
Population Age: Elderly | Gender: Male, Female | |
Trial protocol: ES (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2017-001341-27 | Sponsor Protocol Number: Empire-2017 | Start Date*: 2017-05-29 | |||||||||||
Sponsor Name:Morten Schou | |||||||||||||
Full Title: Empagliflozin in heart failure patients with reduced ejection fraction: A randomized clinical trial (Empire HF) | |||||||||||||
Medical condition: Heart failure with reduced ejection fraction | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2013-000797-30 | Sponsor Protocol Number: SPI-IIT-002 | Start Date*: 2013-10-08 | |||||||||||||||||||||
Sponsor Name:Department of Medical Research, Odense University Hospital, Svendborg Hospital | |||||||||||||||||||||||
Full Title: Inhibition of aldosterone to diminish diffuse myocardial fibrosis in atrial fibrillation | |||||||||||||||||||||||
Medical condition: Paroxysmal and persistent atrial fibrillation | |||||||||||||||||||||||
|
|||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||||||||||||
Trial protocol: DK (Completed) | |||||||||||||||||||||||
Trial results: View results |
EudraCT Number: 2017-000789-31 | Sponsor Protocol Number: RGH201 | Start Date*: 2018-02-09 | |||||||||||
Sponsor Name:Kuopio University Hospital Heart Center | |||||||||||||
Full Title: Clinical development and proof of principle testing of new regenerative VEGF-D therapy for cost-effective treatment of refractory angina. A phase II randomized, double-blinded, placebo-controlled s... | |||||||||||||
Medical condition: Refractory angina | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Ongoing) FI (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2014-004490-17 | Sponsor Protocol Number: 72 | Start Date*: 2014-12-17 | |||||||||||
Sponsor Name:Bipebjerg University Hospital | |||||||||||||
Full Title: Effect of ACE-Inhibition on Microvascular Function in Women with Assessed Microvascular Dysfunction and No Obstructive Coronary Artery Disease. | |||||||||||||
Medical condition: Microvascular dysfunction/microvascular angina | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Female | ||||||||||||
Trial protocol: DK (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2012-000247-27 | Sponsor Protocol Number: AINEP | Start Date*: 2012-02-24 | |||||||||||
Sponsor Name:Fundación Investigación Hospital Ramón y Cajal | |||||||||||||
Full Title: Clinical benefit of diclofenac in patients with acute submassive pulmonary embolism: a randomized clinical trial | |||||||||||||
Medical condition: Acute pulmonary embolism | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2015-002153-35 | Sponsor Protocol Number: GAP | Start Date*: 2015-09-10 | |||||||||||
Sponsor Name:Bispebjerg University Hospital | |||||||||||||
Full Title: Effect of Glucagon-like peptide-1 stimulation on coronary microvascular dysfunction in women with angina pectoris and no obstructive stenosis of major coronary vessels | |||||||||||||
Medical condition: Patients with angina pectoris and coronary microvascular dysfunction without significant stenosis og major coronary vessels | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Female | ||||||||||||
Trial protocol: DK (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2010-019302-16 | Sponsor Protocol Number: 2010GU001B | Start Date*: 2010-09-13 |
Sponsor Name:Royal Brompton and Harefield NHS Foundation Trust | ||
Full Title: A prospective, randomised, placebo-controlled, double blind, multi-centre study of the effects of Irbesartan on aortic dilatation in Marfan syndrome | ||
Medical condition: Marfan Syndrome | ||
Disease: | ||
Population Age: Children, Adolescents, Under 18, Adults | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: View results |
EudraCT Number: 2007-007699-40 | Sponsor Protocol Number: C3BS-C-07-1 | Start Date*: 2009-02-25 | ||||||||||||||||
Sponsor Name:Cardio3 BioSciences | ||||||||||||||||||
Full Title: C-Cure - Safety, feasibility and efficacy of guided bone marrow-derived cardiopoietic mesenchymal stem cells for the treatment of heart failure secondary to ischemic cardiomyopathy | ||||||||||||||||||
Medical condition: C-Cure is indicated for the treatment of heart failure (NYHA class II and III with a Left Ventricular Ejection Fraction > 15 % and <= 40%) secondary to ischemic cardiomyopathy. | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: BE (Completed) | ||||||||||||||||||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
Query did not match any studies.